Groundbreaking Trial Finds That Infrared Light Therapy For Parkinson’s Disease Reduces Symptoms and Improves The Gut Microbiome POSTED ON20 MAY, 2021 BY SUVI Professor of Cardiology at Macquarie University Professor Hosen Kiat, recently gave an exclusive interview to Surfers Health Medical Centre health and wellness writer Suvi Mahonen about the results of their soon to be published trial, led by Australasian Research Institute’s Dr Ann Liebert, which found that infrared light therapy for Parkinson’s disease appears to reduce symptoms of the disease as well as improving the gut microbiome. This is the first known trial worldwide to demonstrate changes in the human gut microbiome following light therapy. The study’s findings will be published in The Journal of Photochemistry & Photobiology, B: Biology in the coming weeks, and an article on this topic will be posted on this blog concurrently. In this video interview, Professor Kiat discusses the significance of the study’s findings, and its relevance for Parkinson’s disease as well as other chronic health conditions including obesity, heart disease, autoimmune diseases and cancers. “It is quite possible that laser will provide a synergistic effect to the currently available therapeutic manoeuvres [to the gut microbiome]”, Professor Kiat says. “It is a no-brainer if it is useful because it is relatively cheap, it is non-invasive and it has zero side effects.” Professor Kiat says that the combination of laser application to the head and abdomen resulted in “… very significant improvements in the symptoms of Parkinson’s disease”.